Issued Patents 2021
Showing 1–1 of 1 patents
| Patent # | Title | Co-Inventors | Date | Approx Value ⓘ |
|---|---|---|---|---|
| 11155876 | K-ras mutations and anti-EGFr antibody therapy | Daniel J. Freeman, Todd Juan | 2021-10-26 | $184,195,000 |
{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Amgen", "item": "https://www.patentleaderboard.com/2021/company/amgen"}, {"@type": "ListItem", "position": 4, "name": "Robert Radinsky", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ro_ln:radinsky-1"}]}
Skip to contentShowing 1–1 of 1 patents
| Patent # | Title | Co-Inventors | Date | Approx Value ⓘ |
|---|---|---|---|---|
| 11155876 | K-ras mutations and anti-EGFr antibody therapy | Daniel J. Freeman, Todd Juan | 2021-10-26 | $184,195,000 |